Lantus, a new long-acting insulin
June 2000
The FDA just approved Lantus, a new long-acting insulin.
It's longer acting than NPH or Ultralente...and doesn't produce peak concentrations like other insulins.
Lantus is a synthetic insulin called insulin glargine. It differs from human insulin by 3 amino acids.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote